Loading...
•
Dec 31, 2019
DexCom Q4 2019 Earnings Report
DexCom's revenue increased driven by volume growth and new patient additions, resulting in GAAP profitability.
Key Takeaways
DexCom reported a strong fourth quarter and fiscal year 2019, with revenue growth of 37% in Q4 and 43% for the full year. The company achieved GAAP profitability for the first time and is well-positioned for long-term growth.
Revenue grew 37% versus the same quarter of the prior year to $462.8 million.
U.S. revenue growth of 34% and international revenue growth of 52%.
GAAP operating income of $101.5 million or 21.9% of revenue.
Commenced launch of G6 into Medicare
DexCom
DexCom
DexCom Revenue by Segment
DexCom Revenue by Geographic Location
Revenue by Segment
Sensor and other Revenue
CapyFin.comHardware Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Dexcom reaffirmed its revenue projection and provided the following gross profit, operating margin, and Adjusted EBITDA margin expectations for full fiscal year 2020:
Positive Outlook
- Revenue of $1.725 billion to $1.775 billion (17% - 20% growth)
- Gross profit margin of approximately 64%
- Non-GAAP operating margin of approximately 13%
- Non-GAAP adjusted EBITDA margin of approximately 23%
Revenue & Expenses
Visualization of income flow from segment revenue to net income